We Work For Health

@weworkforhealth

Bringing together stakeholders to preserve America’s leadership in the life sciences

Joined April 2009

960Following

1KFollowers

Pinned

We Work For Health@weworkforhealth · Jul 25

China is taking the lead in biotech– driving over a third of global pharma acquisitions last year. The U.S. lead in innovation is slipping when it comes to regulation and operations. @Finrow and Sandeep Patel lay out steps to get the U.S. back on top: statnews.com/2025/06/03/us-…

weworkforhealth's tweet card. “There's no reason the U.S. can't pick up the pace to match the global clinical research front-runners without compromising safety,” write Brian Finrow and Sandeep Patel.

Pinned

We Work For Health@weworkforhealth · Jul 23

Now is a pivotal moment to strengthen U.S. medical innovation policy, especially as China and other nations push forward. States like Colorado depend on smart policies to drive economic growth. Learn more from WWH Policy Director Candace DeMatteis: coloradopolitics.com/opinion/colora…

weworkforhealth's tweet card. Smart policymaking and American ingenuity have combined to create an innovation infrastructure that, for several decades, has enabled the United States to lead the world in medical advances. Federal...

Pinned

We Work For Health@weworkforhealth · Jul 10

The most favored nation drug pricing policy does not put American products first. We need policy that fosters competition and patient choice, not #PriceControls. Check out this article from @PennLive: pennlive.com/opinion/2025/0…

weworkforhealth's tweet card. Canada and many European countries apply strict government price controls onto medicine, forcing manufacturers to sell their products at below market rates

Pinned

We Work For Health@weworkforhealth · Jun 26

Policymakers must focus on smart legislation that drives innovation while keeping drug prices accessible and more affordable. Hear insights on the current landscape and what’s needed in this podcast with Ipsita Smolinski and @DuaneSchulthess: omny.fm/shows/vital-he…

120

We Work For Health@weworkforhealth · 20 h

New @VitalTransform research warns the #MFN proposal could gut U.S. biopharma by slashing $2.8T in earnings and sending cutting-edge R&D straight to China. Full report here: vitaltransformation.com/2025/06/everyb…

weworkforhealth's tweet card. Key takeaways If MFN were adopted in Medicare and Medicaid, based upon our preliminary estimate it could lead to 1.3 million fewer jobs over ten years. $2.8 trillion in lost earnings over 10 years...

We Work For Health@weworkforhealth · Jul 22

#PriceControls like #MFN may promise to lower drug costs but, in reality, they hinder innovation and threaten patient health by delaying and denying access to medications. Victoria Ford of @txhbi breaks it down in this must-read article: pressreader.com/usa/austin-ame…

weworkforhealth's tweet card. The U.S. is the world’s leader in the development of lifesaving biopharmaceutical advances and breakthroughs, and Texas plays a significant role in fueling that innovation. Thousands...

We Work For Health@weworkforhealth · Jul 17

China has already challenged U.S. dominance in AI and electric vehicles– now it's targeting biopharma. Last year, China produced 1,250 novel drugs, closing in on the U.S. total of 1,440. More from @business: bloomberg.com/news/features/…

weworkforhealth's tweet card. Chinese biotech's advance has been as ferocious as the nation's breakthrough efforts in AI and EVs, eclipsing the EU and catching up to the US

We Work For Health@weworkforhealth · Jul 16

When it comes to biopharma research & development, America is already the most favored nation, with companies focusing on our health priorities. #MFN would increase prices & cause Americans to lose out on innovative cures. Watch this video from @NPLB_org: youtu.be/6yAzY8ks1rU?si…

We Work For Health@weworkforhealth · Jul 15

As a patient living with chronic illness, @CZ voices concern over the #MFN drug pricing model. With the #IRA already contributing to delays in healthcare, flaws in MFN could further limit timely treatment– putting American patients at greater risk. realclearhealth.com/articles/2025/…

weworkforhealth's tweet card. As a patient living with a chronic illness, there is nothing more discouraging than efforts that stunt medical innovation. This includes policies that knowingly shackle ourselves to backward ideas. Pr

2.0K

We Work For Health@weworkforhealth · Jul 14

North Carolina shows how smart policy fuels #biopharma innovation. Thanks to the Bayh-Dole Act, its universities drive high-tech progress nationwide. Time to double down on what keeps America cutting-edge. More from WWFH Policy Director Candace DeMatteis: ncpoliticalnews.com/news/op-ed-now…

We Work For Health@weworkforhealth · Jul 14

Don't miss the latest briefing by @ITIFdc on the Bayh-Dole Act and university tech transfer, and why it’s key to sustaining innovation for the future. Register now: itif.org/events/2025/07…

weworkforhealth's tweet card. This in-person event on Capitol Hill will explore how academic research, entrepreneurship, and public-private partnerships are shaping innovation ecosystems—and what is needed to strengthen them...

We Work For Health@weworkforhealth · Jul 11

A new @_PILMA study shines a light on the tradespeople behind the labs where life-saving medicines begin. With over 1k major projects from 2019-2024, these skilled workers drive #biopharma innovation. Learn more from our latest blog: weworkforhealth.org/post/how-biote…

We Work For Health Retweeted

THBI@txhbi · Jul 7

📢 THBI & @WeWorkForHealth hosted a webinar last week on the dangers of the Most Favored Nation drug pricing proposal. Experts warned MFN could threaten U.S. innovation, jobs, and patient access to care. Watch the full discussion: vimeo.com/1098239415

158

We Work For Health@weworkforhealth · Jul 9

#IPRights are written in the Constitution. Upholding that vision, the Bayh-Dole Act empowers inventors to bring their innovations to market– fueling the leadership the founding fathers envisioned for America. Watch this video from @BayhDole to learn more: youtu.be/rKF744_zPlA?si…

We Work For Health@weworkforhealth · Jul 7

The #IRA showed what happens when expected returns in biotech drop– investment in innovation dries up. That’s the impact of #PriceControls. #MFN will only make matters worse. More from @InsideSourcesDC: dcjournal.com/trump-policy-t…

weworkforhealth's tweet card. Most people would agree that the scientists and doctors who develop miracle cures for deadly and debilitating diseases are real heroes. Yet, their work is

We Work For Health@weworkforhealth · Jul 3

China’s share of global drug development jumped from 2% to 25%, while the U.S. dropped from 45% to 36%. Something’s off. It’s time to reinvest in America’s biopharma edge. Read more from @FastCompany: fastcompany.com/91342777/china…

weworkforhealth's tweet card. China is catching up to the U.S. in the pharmaceutical business, but it's not too late to turn that around.

We Work For Health@weworkforhealth · Jul 2

When sickness or injury strikes, patients need access to quality care– not delays from harmful policies. To understand how MFN threatens American healthcare, read this issue brief from @NMQF: nmqf.org/resource-libra…

weworkforhealth's tweet card. This issue brief, Most Favored Nation vs. Human Sustainability: How Federal Price Controls Fight Biology—and Americans Lose, examines the potential harms of the federal government’s Most Favored...

We Work For Health@weworkforhealth · Jun 30

#PriceControls discourage innovation, making future treatments harder to access. Read more from @Forbes: forbes.com/sites/waynewin…

We Work For Health@weworkforhealth · Jun 27

260

We Work For Health@weworkforhealth · Jun 25

U.S. biopharmaceutical construction surged from 2019–2024, generating $2.6B in wages for American workers. Innovation doesn’t just save lives– it sustains good-paying jobs. Read the @_PILMA & ICERES report on the link between labor and life-saving cures: unionjobs.pilma.org